Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
MarketMinute.com Stock News
January 02, 2013 at 12:23 PM EST
Synergy Reports Upbeat Trial Results
Synergy Pharmaceuticals Inc. (
) reported upbeat results from a late stage clinical trial of its chronic constipation treatment plecanatide. Shares of the biopharmaceutical climbed 93 cents to $6.19.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Bots go here